register

Digital & Innovation

Local digital health company accesses billion-dollar wearable technology market

Health Industry Hub | March 24, 2021 |

Digital & innovation: Perth based digital health company has launched its new product which enables real-time reporting and insights of personal health metrics for older Australians.

Wearable smart health devices can now be integrated with InteliCare’s app, InteliLiving, to provide personal biometrics in real time, giving the company access to a US$45.7bn market.

The aged care technology company’s new suite of analytics aims to provide enhanced functional capacity to the InteliLiving remote care package through this real time monitoring.

The mobile health apps and associated patient monitoring is a large and growing segment of the digital health market.

InteliCare’s new product update can enable the capture and recording of health data, through integrated smart health tracking devices like Fitbit. This seamless integration allows InteliLiving to tap into the growing wearables market for health and wellbeing tracking.

A total of 1.2 million smart wrist wearables were sold in Australia in 2H20. The market opportunity for InteliCare’s disability offering is also enhanced with this update as it allows carers to build a more complete picture of their clients’ risks.

Instead of carers having the ability to only check on the movement and activity of their loved ones, through current and planned wearable synchronisation, they will be able to monitor heart rate (average and resting), weight and BMI, respiration, temperature, blood oxygenation, blood glucose and activity (i.e. steps).

Using the InteliLiving app, carers can view and track health metrics on a daily, weekly, monthly or longer time frame.

Earlier this month, InteliCare was mentioned in the official Royal Commission into Aged Care final report as a recommended advanced technology to improve aged care services in Australia.

InteliCare’s Chief Executive Jason Waller says this new product update is the first step in a much deeper strategy to drive more efficient care.

“InteliLiving’s health metrics meets an immediate customer need with a free offering,” said Waller.

“It is a clear example of how we are able to leverage our open architecture IoT platform to build and incorporate new products to meet a rapidly evolving industry and remain ahead of the market.”

The initial product will be a free addition to the current product suite, but as further advances are made, additional subscription options will become available.


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


News & Trends - MedTech & Diagnostics

Federal government invests in Siemens Healthineers scanner to 'reduce wait times' for cancer diagnosis

Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]

More


News & Trends - MedTech & Diagnostics

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]

More


News & Trends - Biotechnology

CSL's world-first gene therapy heads for MSAC assessment

CSL’s world-first gene therapy heads for MSAC evaluation

Health Industry Hub | April 23, 2024 |

Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]

More


This content is copyright protected. Please subscribe to gain access.